Physician profile
Kerry Byrnes
NPI 1982787099
$791.20
in general payments reported to CMS, 2019-2025
18 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $77.03 · 2021: $118 · 2022: $161 · 2023: $40.07 · 2024: $81.29 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $108.17 | 2021-2022 | |
| Organogenesis INC. | $93.09 | 2021-2023 | Puraply |
| Biowound Solutions, INC. | $89.85 | 2025 | Bio-Connekt |
| Cook Medical LLC | $83.21 | 2019-2020 | |
| Boston Scientific Corporation | $54.35 | 2020-2023 | |
| Braintree Laboratories, INC. | $51.55 | 2019-2021 | |
| Tactile Systems Technology INC | $42.95 | 2019 | |
| Intuitive Surgical, INC. | $40.80 | 2022 | |
| Abbvie INC. | $37.76 | 2021-2024 | |
| Convatec INC. | $32.82 | 2024-2025 | |
| Medtronic, INC. | $32.56 | 2025 | Pteye Parathyroid Detection System |
| Kerecis Limited | $25.01 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $21.56 | 2024 | |
| Shire North American Group INC | $18.77 | 2019 | |
| Integra Lifesciences Corporation | $17.31 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $14.45 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.29 | 2019 | |
| Innocoll Pharmaceuticals Limited | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Byrnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.